10-K: Enfusion to be Acquired by Clearwater Analytics in $1.5 Billion Deal

Enfusion, Inc. will be acquired by Clearwater Analytics in a merger valued at approximately $1.5 billion, combining cash and stock.

Summary

• Enfusion, Inc. has filed its annual report on Form 10-K for the fiscal year ended December 31, 2024.
• The company has entered into a merger agreement with Clearwater Analytics Holdings, Inc. (Clearwater) for approximately $1.5 billion.
• Enfusion's stockholders will receive $11.25 per share, consisting of $5.85 in cash and $5.40 in Clearwater's Class A common stock.
• The merger is subject to customary closing conditions, including stockholder approval and regulatory approvals.
• Total revenues for 2024 were $201.6 million, a 15.5% increase from $174.5 million in 2023.
• Recurring subscription-based revenues were $200.2 million, representing 99.3% of total revenues.
• Net income for 2024 was $3.9 million, compared to $9.3 million in 2023.
• The company had 916 clients as of December 31, 2024.
• As of December 31, 2024, the company had cash and cash equivalents of $54.5 million and $99.9 million in available borrowing capacity under its credit agreement.
• The company estimates the amount of existing tax basis and basis adjustments acquired to be approximately $374.4 million as of December 31, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the acquisition provides immediate value, the decrease in net income and potential disruptions from the merger temper the overall outlook.

Positives

• The acquisition by Clearwater Analytics provides immediate value to Enfusion's stockholders.
• Recurring subscription revenue remains high at 99.3% of total revenue, indicating a stable business model.
• Revenue continues to grow, with a 15.5% increase in total revenue from 2023 to 2024.
• The company maintains a strong global presence, with clients in the Americas, EMEA, and APAC regions.
• The company has a Net Dollar Retention Rate of 106.4%, indicating strong client loyalty and expansion.

Negatives

• Net income decreased from $9.3 million in 2023 to $3.9 million in 2024.
• The merger agreement could disrupt business relationships and divert management attention.
• The company is subject to a termination fee of $52.325 million if the merger agreement is terminated under certain circumstances.
• The company's Revenue Churn Rate for the year ended December 31, 2024 was 6.0%, and Adjusted Revenue Churn Rate was 2.8%.

Risks

• The merger with Clearwater is subject to regulatory and stockholder approvals and may not be completed.
• The pendency of the merger could adversely affect Enfusion's business relationships and operations.
• The company's future performance is subject to various risks and uncertainties, including competition, technological changes, and economic conditions.
• The company's international operations are subject to regulatory, economic, and political risks.
• The company's failure to comply with data privacy, protection, and security regulations could impose additional costs and liabilities.

Future Outlook

The company expects to continue to invest in its business to support growth and capitalize on its market opportunity. The merger with Clearwater is anticipated to close in the second quarter of 2025, subject to customary closing conditions.

Management Comments

• Management believes that current sources of liquidity, cash flows from operations, and existing available cash, together with other available external financing sources, will be adequate to fund operating and capital needs for at least the next 12 months.

Industry Context

The investment management software and services market is highly competitive, with Enfusion competing against both established providers and new entrants. The acquisition by Clearwater reflects a trend of consolidation in the financial technology sector.

Comparison to Industry Standards

• BlackRock's Aladdin, Broadridge, State Street Alpha, SS&C, SimCorp, Bloomberg AIM, LayerOne and Coremont are listed as competitors, but many face challenges with single-tenant, cloud-migrated systems.
• New entrants often provide single point solutions such as trading, fund administration or portfolio analytics that are intended to be coupled with other offerings.

Related Party Transactions

• On June 15, 2023, the Company sold 1.2 million shares of Class A common stock to FTV Investment Holdings, L.P. (FTV Holdings) and an affiliate in a private placement.
• In the first quarter of 2023, the Company received approximately $1.5 million from the U.S. Treasury in the form of a tax refund owed to FTV Enfusion Holdings, Inc. (FTV Enfusion), which prior to the Companys initial public offering in 2021 was a Blocker Company through which FTV Fund IV held its equity interests in Enfusion Ltd. LLC.

Stakeholder Impact

• Shareholders will receive $11.25 per share in a combination of cash and Clearwater stock.
• Employees face uncertainty regarding their roles and responsibilities following the merger.
• Customers may experience changes in the products and services offered by the combined company.
• Suppliers and creditors may be affected by the financial strength and stability of the combined company.

Next Steps

• Obtain stockholder approval for the merger with Clearwater.
• Obtain regulatory approvals for the merger.
• Satisfy other customary closing conditions for the merger.
• Integrate Enfusion's business with Clearwater following the completion of the merger.

Key Dates